Electrophoresis Market Potential Growth, Share, Demand And Analysis Of Key Players- Analysis Forecasts To 2032

Global demand for electrophoresis market share is set to increase at a 4.7% CAGR from 2022 to 2032, with an estimated market value of around US$ 2.2 Bn as of 2022. As per Future Market Insights’ projections, reagents and consumables held about 48.7% of the global market share in 2021.

Electrophoresis has developed into one of the most universal analytical practices in the life sciences sector. Cutting-edge technology and automation in this process offers unparalleled reproducibility and ease of use and decreased hands-on time.

Furthermore, convenience of automated systems over manual systems and obtainability of prompt results are anticipated to fuel the electrophoresis market. The growing prevalence of cancer and expansion in research and development will drive demand, providing a vast potential for electrophoresis players to address chronic illness. Healthcare establishments are promptly adopting devices such as electrophoresis equipment to carry out biological research and drug discovery.

Agarose gel electrophoresis is an essential technique in all investigations concerning nucleic acids. The RFLP (restriction fragment length polymorphism) analysis of chromosomal DNA has been a valuable method in localization of genes for determination of diseases, genome mapping, genetic disorders, and paternity test.

These methods also form the base of DNA fingerprinting, where electrophoresis isolates fragments of DNA. This procedure allows to compare human blood samples obtained from a crime scene to blood samples from a suspect.

2016-2021 Electrophoresis Market Historic Outlook Vs 2022-2032 Forecast

The market value for electrophoresis held nearly 32.9% of the overall US$ 6.4 Bn genomics and proteomics market in 2021.

Growth in the global electrophoresis market is propelled by the genomics market, as gel electrophoresis has wide-ranging applications in genomics research. Gel electrophoresis has applications in the field of genomics to produce artificial chromosome libraries, chromosomal assignments of genes and genetic mapping.

Growing practices in drug development and DNA and protein mapping have a subsequent impact upon the growth in the electrophoresis market. Moreover, rising academic research has also aided in the advancement of electrophoresis utilization, thereby boosting sales in the market.

Growing incidence of chronic diseases such as genetic disorders, infectious diseases, and cancer across the globe is underpinning demand for electrophoresis equipment. With the mounting cases of chronic diseases, rapid diagnosis and treatment are essential. This has led to electrophoresis being utilized within clinical laboratory setup to measure the lipoproteins by using enzymatic staining of triglycerides and cholesterol to detect cardiovascular diseases and other chronic illness, such as diabetes.

A paradigm shift from genomics to proteomics market has led to technological advancements, thus helping drug discovery researchers by providing added sensitivity, higher throughput and increased resolution from conventional protein research tools.

Government funding and technological developments are projected to boost market expansion. A rise in genetic testing volumes, on the other hand, is predicted to counteract a drop in average selling prices of instruments and services. The growing use of genomics research and testing, together with the falling cost of instruments and consumables, will create opportunities for growth in the market.

Technological advancements in electrophoresis equipment such as the availability of automated systems over manual systems and availability of rapid results are expected to fuel the electrophoresis market. The market is expected to offer an absolute $ opportunity of US$ 88.3 Mn over the forecast period.

What are the Key Opportunities for Electrophoresis Manufacturers?

Rising efforts towards personalization of medication, as well as tailored targeted therapies owing to the wide presence of chronic diseases and large patient population have resulted in the growth of the electrophoresis market. Drug discovery drives the global electrophoresis market significantly as the analysis of a new drug entity plays a crucial role in its initial stage to pass through various qualifying tests. 

Demand for innovative drugs and therapies has forced companies to increase investments in drug discovery. This is expected to boost the growth in the electrophoresis equipment and accessories market.  Analytical instruments used in research and development are expected to deliver accurate and efficient results. Capillary electrophoresis equipment is used in this application. Thus, increasing demand for drug discovery would also boost the electrophoresis market.

Emerging economies such as India, China, Brazil and Mexico are investing in healthcare infrastructure and research capacities for drug and therapy discovery. Most companies based in North America and Europe outsource drug research operations and clinical trials to countries such as India and China. Availability of skilled and qualified labour across these countries has expanded the opportunity for attracting outsourcing of biotech projects.

Moreover, governments across these economies have started taking steps to accelerate the overall growth of domestic biotech industry by offering exemptions in tax for research and development, increasing overall funding and budgets and attracting foreign direct investments.

What is Driving the U.S. Electrophoresis Market?

“Increasing Preference for Horizontal Electrophoresis in the U.S. Will Drive Growth”

The U.S. dominated the North America market with a total market share of about 92.8% in 2021, and is projected to continue experiencing high growth throughout the forecast period. The U.S. is one of the most lucrative markets for electrophoresis owing to the amalgamation of a strong healthcare infrastructure along with technologically advanced procedures, rising patient population with chronic disorders, and relatively high healthcare expenditure.

Why is the Germany Electrophoresis Market Considered Lucrative Market?

“High Expenditure on Drug Research Will Boost Sales of Electrophoresis Equipment”

Germany is set to exhibit a CAGR of nearly 5.2% in the Europe electrophoresis market during the forecast period. Rising research and development activities to create a viable base for novel and therapeutic drugs within the country as well as presence of a well-established healthcare infrastructure are some factors supporting the development of electrophoresis in Germany.

What Makes China an Emerging Market for Electrophoresis?

“Growing Trend of Medical Tourism in China Will Fuel Sales of Electrophoresis”

China held about 43.4% of the East Asia market share in 2021, and is projected to expand at a CAGR of 5.2% during the forecast period. Growth can be attributed to growing disposition of automated technologies into an integrated platform for drug discovery and development, growing healthcare costs and rapidly improving medical setup in China.

Category-wise Insights

Which Product in the Electrophoresis Market is Driving Growth?

“Demand for Reagents and Consumables to Remain High”

Based on product type, sales of reagents and consumables are expected to grow at a CAGR of 4.6% over the forecast period. Wide utilization of reagents and consumables in electrophoresis and associated techniques such as PCR will continue pushing sales in this segment.

Which End User Benefits the Most by the Employment of Electrophoresis?

“Sales Across Pharma and Biotech Companies Will Continue Gaining Traction”

In terms of end users, the pharma & biotech companies segment accounted for more than 26.7% of the total market share in 2021. With rising breakthroughs in therapeutic approach to drug development, the pharma and biotech companies will continue dominating the market over the forecast period.

Competitive Landscape       

Key players operating in the global electrophoresis market are investing in collaborations with the academic and research institutes for growth and innovation in electrophoresis. They are also focusing on developing different automated electrophoresis systems which have integrated software for efficient use of this technique. With the increase in research and development in this field, various applications such as food safety and quality control have come into picture. For instance:

  • In September 2019, Bio-Rad Laboratories, Inc. announced the launch of the Science of Opioid Dependence Kit, which offers high school and undergraduate educators a simple hands-on DNA electrophoresis activity to teach complex genetics owing to the opioid crisis.
  • In September 2021, SCIEX announced its state-of-the-art capillary electrophoresis solution, the “BioPhase 8800 system”. The system is an advanced, novel multi-capillary system with the ability to process 8 samples at the same time, ensuring sample consistency and providing reliable and precise results.

Key Market Segments Covered in Electrophoresis Industry Research

By Product:

  • Instruments
    • Horizontal Systems
    • Vertical Systems
    • Capillary Electrophoresis Systems
    • Automatic Electrophoresis Systems
  • Reagents and Consumables
    • Gel
      • Polyacrylamide Gel Electrophoresis
      • Agarose Gel Electrophoresis
      • Others
    • Buffers & Others
  • Software

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Pharma & Biotech Companies
  • CROs and CMOs
  • Academic & Research Institutes
  • Forensic Laboratories

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

For more Information @ https://www.futuremarketinsights.com/reports/electrophoresis-market  

Comments

Post a Comment

Popular posts from this blog

Mammography Market Demand, Scope and Future Estimation until 2032

  The global  mammography market    is estimated to be worth around  US$ 1.7 Billion  in 2022. However, with rising prevalence of breast cancer at an alarming rate the overall demand for mammography systems is anticipated to grow at around  6.5%  to  9% CAGR  between 2022 and 2032, totaling over  US$ 3.4 Billion  by 2032. Mammography  is a modern non-invasive medical imaging and diagnostic technique that uses low-dose X-rays to monitor breast tissues for the presence of tumor. It has become one of the most commonly used techniques for checking abnormalities in the absence of any symptoms. It has significantly aided in reducing breast cancer mortality rates worldwide. Increasing prevalence of breast cancer across the world along with growing awareness about the benefits of screening and early diagnosis of breast cancer is providing a major impetus to the growth of mammography market. It is one of the most common f...
Read more

Interventional Cardiology Devices Market Key Players, SWOT Analysis, Key Indicators & Forecast By 2032

  The  interventional cardiology devices market demand  is expected to grow at an  8.4%  CAGR from  USD 16.4  Billion in 2022 to USD  36.9  Billion by 2032. The fast expansion of the geriatric population and the corresponding increase in the prevalence of coronary artery diseases, the approval of new and sophisticated products, and the growing incidence of diabetes are all driving growth in the interventional cardiology devices market. However, the availability of alternative therapies, as well as product failures and recalls, are the primary factors projected to hinder interventional cardiology devices market growth over the projection period. COVID-19 has had a global influence on every element of the medical device business, including the market for interventional cardiology equipment. Despite the fact that emergency and outpatient treatments are offered in cardiology departments, the number of patient visits to hospitals has decreased dra...
Read more

Cardiac Rehabilitation Market Research, Segmentation, Key Players Analysis & Forecast By 2032

  The  cardiac rehabilitation market share  is likely to expand its roots in the global market at an average CAGR of 6.0% between 2022 and 2032. The market is valued at US$ 2.1 Bn in 2022 and is likely to reach US$ 3.8 Bn by 2032. Previously, the market was thriving at a slightly higher CAGR of 6.5% (2015-2021), ensuring a market size of US$ 2 Billion in 2021. “Growing lifestyle-related diseases like diabetes and cardiovascular strokes along with the technological revolution in the healthcare sector, helping the patients going through heart attack, heart valve surgeries, heart failures.” An unhealthy lifestyle is leading to new heart-related diseases like heart attacks and heart failure. The technologically advanced tools that enable easy surgery processes drive the sales of cardiac rehabilitation systems. These systems help end users with exercises, diet, stress management and training, managing and monitoring the daily progress of the health routine. It is largely consu...
Read more